Pengbo Liu1, Xiaoqin Wang, Joong-Chul Lee, Peter Teunis, Senke Hu, Helen Tang Paradise, Christine Moe. 1. From the *Rollins School of Public Health, Emory University, Atlanta, GA; †School of Public Health, Xi'an Jiaotong University, Xi'an, China; ‡National Institute of Public Health and the Environment, Bilthoven, The Netherlands; and §Boston University Medical Center, Boston, MA.
Abstract
BACKGROUND: Noroviruses (NoVs) are a leading cause of viral diarrhea in young children. Secretor status has been confirmed to be linked with Norwalk virus (NoV GI.1) infection but there is limited information about whether secretor genotypes are associated with pediatric NoV epidemic strains in vivo. METHODS: In this study, fecal specimens and serum samples were collected from 124 hospitalized children with acute diarrhea in Xi'an, China. TaqMan real-time reverse transcription polymerase chain reaction was used to detect NoVs in fecal samples, and NoV-positive samples were further verified using conventional reverse transcription polymerase chain reaction and sequenced. DNA was extracted from sera and TaqMan single-nucleotide polymorphism genotyping assay was applied to determine the FUT2 A385T polymorphism. RESULTS: Only NoV GII.3 and GII.4 genotypes were found in NoV-positive samples, and NoVs were detected in 25% (15/60), 40.5% (17/42) and 9.1% (2/22) of children with homozygous secretor genotype (Se 385 Se 385), heterozygous secretor genotype (Se 385 se 385) and homozygous weak secretor genotype (se 385 se 385), respectively. Children with secretor genotypes Se 385 Se 385 and Se 385 se 385 were significantly (P < 0.05) more susceptible to combined NoV GII.3 and GII.4 infections than children with weak secretor genotype se 385 se 385. CONCLUSIONS: These findings indicate that secretor positivity is significantly associated with GII.3 and GII.4 infections in Chinese pediatric diarrheal disease and the weak secretor phenotype does not completely protect children from GII.3 and GII.4 infections.
BACKGROUND: Noroviruses (NoVs) are a leading cause of viral diarrhea in young children. Secretor status has been confirmed to be linked with Norwalk virus (NoV GI.1) infection but there is limited information about whether secretor genotypes are associated with pediatric NoV epidemic strains in vivo. METHODS: In this study, fecal specimens and serum samples were collected from 124 hospitalized children with acute diarrhea in Xi'an, China. TaqMan real-time reverse transcription polymerase chain reaction was used to detect NoVs in fecal samples, and NoV-positive samples were further verified using conventional reverse transcription polymerase chain reaction and sequenced. DNA was extracted from sera and TaqMan single-nucleotide polymorphism genotyping assay was applied to determine the FUT2A385T polymorphism. RESULTS: Only NoV GII.3 and GII.4 genotypes were found in NoV-positive samples, and NoVs were detected in 25% (15/60), 40.5% (17/42) and 9.1% (2/22) of children with homozygous secretor genotype (Se 385 Se 385), heterozygous secretor genotype (Se 385 se 385) and homozygous weak secretor genotype (se 385 se 385), respectively. Children with secretor genotypes Se 385 Se 385 and Se 385 se 385 were significantly (P < 0.05) more susceptible to combined NoV GII.3 and GII.4 infections than children with weak secretor genotype se 385 se 385. CONCLUSIONS: These findings indicate that secretor positivity is significantly associated with GII.3 and GII.4 infections in Chinese pediatric diarrheal disease and the weak secretor phenotype does not completely protect children from GII.3 and GII.4 infections.
Authors: Robert L Atmar; David I Bernstein; Clayton D Harro; Mohamed S Al-Ibrahim; Wilbur H Chen; Jennifer Ferreira; Mary K Estes; David Y Graham; Antone R Opekun; Charles Richardson; Paul M Mendelman Journal: N Engl J Med Date: 2011-12-08 Impact factor: 91.245
Authors: Robert Frenck; David I Bernstein; Ming Xia; Pengwei Huang; Weiming Zhong; Susan Parker; Michelle Dickey; Monica McNeal; Xi Jiang Journal: J Infect Dis Date: 2012-08-20 Impact factor: 5.226
Authors: Daniel C Payne; Jan Vinjé; Peter G Szilagyi; Kathryn M Edwards; Mary Allen Staat; Geoffrey A Weinberg; Caroline B Hall; James Chappell; David I Bernstein; Aaron T Curns; Mary Wikswo; S Hannah Shirley; Aron J Hall; Benjamin Lopman; Umesh D Parashar Journal: N Engl J Med Date: 2013-03-21 Impact factor: 91.245
Authors: Rebecca L Currier; Daniel C Payne; Mary A Staat; Rangaraj Selvarangan; S Hannah Shirley; Natasha Halasa; Julie A Boom; Janet A Englund; Peter G Szilagyi; Christopher J Harrison; Eileen J Klein; Geoffrey A Weinberg; Mary E Wikswo; Umesh Parashar; Jan Vinjé; Ardythe L Morrow Journal: Clin Infect Dis Date: 2015-03-05 Impact factor: 9.079
Authors: Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount Journal: Annu Rev Genet Date: 2017-08-30 Impact factor: 16.830
Authors: Sheila J Barton; Robert Murray; Karen A Lillycrop; Hazel M Inskip; Nicholas C Harvey; Cyrus Cooper; Neerja Karnani; Irma Silva Zolezzi; Norbert Sprenger; Keith M Godfrey; Aristea Binia Journal: J Infect Dis Date: 2019-02-15 Impact factor: 5.226
Authors: Yaoska Reyes; Fredman González; Lester Gutiérrez; Patricia Blandón; Edwing Centeno; Omar Zepeda; Christian Toval-Ruíz; Lisa C Lindesmith; Ralph S Baric; Nadja Vielot; Marta Diez-Valcarce; Jan Vinjé; Lennart Svensson; Sylvia Becker-Dreps; Johan Nordgren; Filemón Bucardo Journal: J Infect Dis Date: 2022-01-05 Impact factor: 7.759